← Leaderboards
Piotr Rychahou
Ohio State University
$324,149
Attributed
$972,447
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $497K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$972,447 · 1
By mechanism
R01$972,447 · 1
Top collaborators
- Bin Guo2 shared
- Peixuan Guo2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Alexander E Davies$598,565
- Ly James Lee$3,875,706
- Ming You$26,875,453
- Susan R Mallery$15,292,540
- Laura A. Kresty$2,875,032
Others in their field
Other Rising Stars on “Aptamer”
- Jun-Chau Chien · University Of California Berkeley$2,328,157
- Maral Mousavi · University Of Southern California$2,180,213
- Abhichart Krissanaprasit · Helixomer, Inc.$2,042,027
- Prasoon K Diwakar · South Dakota State University$1,333,333
- Srinivas Janaswamy · South Dakota State University$1,333,333
- Febina Mathew · South Dakota State University$1,333,333
Research focus
AptamerBindingBiodistributionCancer CellCancer EtiologyCancer TherapyCellsCessation Of LifeChargeChemical StabilityChimeric ProteinsCodeColonColon CarcinomaColorectal CancerComplexCrispr/Cas TechnologyCytosolDensityDensity Gradient CentrifugationDesignDrug Delivery SystemsDrug KineticsAntibody Therapy
Grant awards (2)
Mechanism and approach to inactivate mutant KRAS of lung metastatic colon cancer by RNA-ligand-displaying exosome to co-deliver dCas9--gRNA ribonucleoprotein complex and KRAS siRNA$475,445
R01 · FY2025 · CA
Mechanism and approach to inactivate mutant KRAS of lung metastatic colon cancer by RNA-ligand-displaying exosome to co-deliver dCas9--gRNA ribonucleoprotein complex and KRAS siRNA$497,002
R01 · FY2024 · CA